These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22774997)

  • 21. Clinical experience with bemiparin.
    Abad Rico JI; Lozano Sánchez FS; Rocha E
    Drugs; 2010 Dec; 70 Suppl 2():25-33. PubMed ID: 21162607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.
    Willey VJ; Bullano MF; Hauch O; Reynolds M; Wygant G; Hoffman L; Mayzell G; Spyropoulos AC
    Clin Ther; 2004 Jul; 26(7):1149-59. PubMed ID: 15336480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thromboembolism prophylaxis conversion in nonsurgical inpatients.
    Carroll DN; Hudson EB
    Ann Pharmacother; 2003 Sep; 37(9):1194-6. PubMed ID: 12921498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants.
    Streiff M; Milentijevic D; McCrae KR; Laliberté F; Lejeune D; Lefebvre P; Schein J; Khorana AA
    J Med Econ; 2019 Nov; 22(11):1134-1140. PubMed ID: 31106638
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
    Santamaría A; Juárez S; Reche A; Gómez-Outes A; Martínez-González J; Fontcuberta J;
    Int J Clin Pract; 2006 May; 60(5):518-25. PubMed ID: 16700847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients.
    Gussoni G; Foglia E; Frasson S; Casartelli L; Campanini M; Bonfanti M; Colombo F; Porazzi E; Ageno W; Vescovo G; Mazzone A;
    Thromb Res; 2013 Jan; 131(1):17-23. PubMed ID: 23141845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboprophylaxis in medically ill patients at risk for venous thromboembolism.
    Burleigh E; Wang C; Foster D; Heller S; Dunn D; Safavi K; Griffin B; Smith J
    Am J Health Syst Pharm; 2006 Oct; 63(20 Suppl 6):S23-9. PubMed ID: 17032931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compliance with current VTE prophylaxis guidelines and risk factors linked to complications of VTE prophylaxis in medical inpatients: a prospective cohort study in a Spanish internal medicine department.
    Novo-Veleiro I; Alvela-Suárez L; Costa-Grille A; Suárez-Dono J; Ferrón-Vidan F; Pose-Reino A
    BMJ Open; 2018 May; 8(5):e021288. PubMed ID: 29764885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicentre controlled pre-post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients.
    Stelfox HT; Brundin-Mather R; Soo A; Parsons Leigh J; Niven DJ; Fiest KM; Doig CJ; Zuege DJ; Kushner B; Clement F; Straus SE; Cook DJ; Bagshaw SM; Sauro KM
    Intensive Care Med; 2019 Feb; 45(2):211-222. PubMed ID: 30707246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity.
    Amin A; Kartashov A; Ngai W; Steele K; Rosenthal N
    Front Cardiovasc Med; 2023; 10():1163684. PubMed ID: 37396589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge.
    Wang L; Sengupta N; Baser O
    Thromb J; 2011 Oct; 9(1):15. PubMed ID: 21995820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
    Huse DM; Cummins G; Taylor DC; Russell MW
    Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.
    Deitelzweig SB; Becker R; Lin J; Benner J
    Thromb Haemost; 2008 Nov; 100(5):810-20. PubMed ID: 18989525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboembolism incidence and prophylaxis during vaginal delivery hospitalizations.
    Friedman AM; Ananth CV; Prendergast E; Chauhan SP; D'Alton ME; Wright JD
    Am J Obstet Gynecol; 2015 Feb; 212(2):221.e1-12. PubMed ID: 25240092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis.
    Amin A; Neuman WR; Lingohr-Smith M; Menges B; Lin J
    Adv Ther; 2019 Jan; 36(1):59-71. PubMed ID: 30543037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.
    Turpie AG; Norris TM
    Thromb Haemost; 2004 Jul; 92(1):3-12. PubMed ID: 15213839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
    Caprini JA; Arcelus J; Sehgal LR; Cohen EB; Reyna JJ
    Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study.
    Blin P; Samama CM; Sautet A; Benichou J; Lignot-Maleyran S; Lamarque S; Lorrain S; Lassalle R; Droz-Perroteau C; Mismetti P; Moore N
    Pharmacol Res; 2019 Mar; 141():201-207. PubMed ID: 30583081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.